載入...
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer
BACKGROUND: This retrospective analysis was planned as a direct comparison of taxanes plus trastuzumab to the less toxic combination of oral vinorelbine (OV) plus trastuzumab as a first-line therapy for metastatic HER2-positive breast cancer. PATIENTS AND METHODS: Patients (n = 76) receiving either...
Na minha lista:
| 發表在: | Breast Care (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
S. Karger GmbH
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4322687/ https://ncbi.nlm.nih.gov/pubmed/25759615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368330 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|